KIT and schwannoma: The main turning point happened thanks to the identification of CD117 antigen, which proved helpful in the distinction between GISTs, typically CD117-positive, and the other group of spindle cell malignancies originating from the GI tract, including lipomas, schwannomas, leiomyomas, and hemangiomas, which are usually CD117-negative [6].